Ilginatinib maleateProduct ingredient for Ilginatinib
- Name
- Ilginatinib maleate
- Drug Entry
- Ilginatinib
NS-018 has been used in trials studying the treatment of Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, and Post-Essential Thrombocythemia Myelofibrosis.
- Accession Number
- DBSALT003440
- Structure
- Synonyms
- (S)-N-(1-(4-FLUOROPHENYL)ETHYL)-4-(1-METHYL-1H-PYRAZOL-4-YL)-N'-(PYRAZIN-2-YL)PYRIDINE-2,6-DIAMINE MALEATE / 2,6-PYRIDINEDIAMINE, N2-((1S)-1-(4-FLUOROPHENYL)ETHYL)-4-(1-METHYL-1H-PYRAZOL-4-YL)-N6-2-PYRAZINYL-, (2Z)-2-BUTENEDIOATE (1:1) / N-[(1S)-1-(4- fluorophenyl)ethyl]-4-(1-methyl-1H-pyrazol-4-yl)-N'-(pyrazin-2-yl)pyridine-2,6- diamine maleate / N-[(1S)-1-(4- fluorophenyl)ethyl]-4-(1-methyl-1H-pyrazol-4-yl)-N'-(pyrazin-2-yl)pyridine-2,6-diamine maleate / NS-018 MALEATE
- UNII
- 8P0KTT2T1Z
- CAS Number
- 1354799-87-3
- External Links
- Not Available
- Predicted Properties
- Not Available
